Juan Hu

1.3k total citations
45 papers, 994 citations indexed

About

Juan Hu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Juan Hu has authored 45 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cancer Research. Recurrent topics in Juan Hu's work include Cardiac Fibrosis and Remodeling (8 papers), Cardiac Arrhythmias and Treatments (5 papers) and Cardiac pacing and defibrillation studies (4 papers). Juan Hu is often cited by papers focused on Cardiac Fibrosis and Remodeling (8 papers), Cardiac Arrhythmias and Treatments (5 papers) and Cardiac pacing and defibrillation studies (4 papers). Juan Hu collaborates with scholars based in China, Macao and United States. Juan Hu's co-authors include Zhimin Du, Jing Guo, Congxin Huang, Ye Yuan, Huibin Liu, Yan Wang, Zheng‐Hong Qin, Li Luo, An Hong and Yulan Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Frontiers in Immunology.

In The Last Decade

Juan Hu

43 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Hu China 20 469 199 193 160 121 45 994
Junjie Guo China 17 633 1.3× 176 0.9× 255 1.3× 98 0.6× 100 0.8× 49 1.2k
Yu‐Lan Yeh Taiwan 22 542 1.2× 200 1.0× 156 0.8× 190 1.2× 229 1.9× 56 1.1k
Xian Wang China 19 385 0.8× 139 0.7× 116 0.6× 181 1.1× 86 0.7× 77 1.4k
Dan Han China 23 479 1.0× 140 0.7× 150 0.8× 155 1.0× 99 0.8× 70 1.3k
Chao Ye China 20 551 1.2× 190 1.0× 252 1.3× 114 0.7× 77 0.6× 59 1.1k
Lei Peng China 21 570 1.2× 100 0.5× 89 0.5× 188 1.2× 122 1.0× 49 1.4k
Haiyu Li China 21 735 1.6× 93 0.5× 373 1.9× 162 1.0× 62 0.5× 66 1.3k
Zhijing Zhao China 19 380 0.8× 189 0.9× 89 0.5× 208 1.3× 74 0.6× 43 963

Countries citing papers authored by Juan Hu

Since Specialization
Citations

This map shows the geographic impact of Juan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Hu more than expected).

Fields of papers citing papers by Juan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Hu. The network helps show where Juan Hu may publish in the future.

Co-authorship network of co-authors of Juan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Hu. A scholar is included among the top collaborators of Juan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Hu. Juan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Boshen, Fei Li, Juan Hu, et al.. (2024). UBE2L3 promotes benzene-induced hematotoxicity via autophagy-dependent ferroptosis. Ecotoxicology and Environmental Safety. 283. 116773–116773.
2.
Hu, Juan, Jing Yan, Yijie Chen, et al.. (2023). ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner. BMC Cancer. 23(1). 1114–1114. 2 indexed citations
3.
Song, Weifeng, Zhen Chen, Meng Zhang, et al.. (2023). Bilobalide Prevents Apoptosis and Improves Cardiac Function in Myocardial Infarction. Molecular Biotechnology. 66(3). 442–453. 1 indexed citations
4.
Yan, Lijie, Jintao Wu, Xian‐Wei Fan, et al.. (2023). Analysis of risk factors and short-term prognostic factors of arrhythmia in patients infected with mild/moderate SARS-CoV-2 Omicron variant. Frontiers in Medicine. 10. 1 indexed citations
6.
Zhang, Futao, Xiaojie Liu, Leiming Zhang, et al.. (2023). Efficacy of catheter ablation for atrial fibrillation in patients with significant functional mitral regurgitation. Medicine. 102(10). e33231–e33231. 3 indexed citations
7.
Yu, Jia, Rongfang He, Xiaoyan Yang, et al.. (2022). LINC01234 Accelerates the Progression of Breast Cancer via the miR-525-5p/Cold Shock Domain-Containing E1 Axis. Disease Markers. 2022. 1–16. 5 indexed citations
8.
Zhang, Hui, Qi Xie, & Juan Hu. (2022). Neuroprotective Effect of Physical Activity in Ischemic Stroke: Focus on the Neurovascular Unit. Frontiers in Cellular Neuroscience. 16. 860573–860573. 9 indexed citations
9.
Hu, Juan, Li Li, Haitao Yang, et al.. (2021). PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation. Journal of Cellular and Molecular Medicine. 25(14). 6746–6759. 14 indexed citations
10.
Tang, Lu, et al.. (2021). Dexpramipexole attenuates myocardial ischemia/reperfusion injury through upregulation of mitophagy. European Journal of Pharmacology. 899. 173962–173962. 24 indexed citations
11.
Yuan, Ye, Juan Hu, Wei Zhao, et al.. (2020). Aloe Emodin Reduces Cardiac Inflammation Induced by a High-Fat Diet through the TLR4 Signaling Pathway. Mediators of Inflammation. 2020. 1–12. 39 indexed citations
12.
Hang, Pengzhou, Juan Hu, Yuyang Zheng, et al.. (2020). Aloe-emodin exerts cholesterol-lowering effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats. Acta Pharmacologica Sinica. 41(8). 1085–1092. 31 indexed citations
13.
Guo, Jing, Huibin Liu, Chuan Sun, et al.. (2019). MicroRNA-155 Promotes Myocardial Infarction-Induced Apoptosis by Targeting RNA-Binding Protein QKI. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 49 indexed citations
14.
Hu, Juan, Congxin Huang, Ji‐Peng Zhou, et al.. (2019). Inhibition of microRNA-155 attenuates sympathetic neural remodeling following myocardial infarction via reducing M1 macrophage polarization and inflammatory responses in mice. European Journal of Pharmacology. 851. 122–132. 49 indexed citations
15.
Hu, Juan, Congxin Huang, Yin Zhang, et al.. (2019). MicroRNA-155 inhibition attenuates endoplasmic reticulum stress-induced cardiomyocyte apoptosis following myocardial infarction via reducing macrophage inflammation. European Journal of Pharmacology. 857. 172449–172449. 41 indexed citations
16.
Yang, Di, Huibin Liu, Juan Hu, et al.. (2019). The long non-coding RNA TUG1-miR-9a-5p axis contributes to ischemic injuries by promoting cardiomyocyte apoptosis via targeting KLF5. Cell Death and Disease. 10(12). 908–908. 43 indexed citations
18.
Hu, Juan, et al.. (2016). Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1/2 and p38-MAPK pathways. European Journal of Pharmacology. 789. 319–327. 56 indexed citations
20.
Qian, Kun, et al.. (2005). Differentiation of endometrial stromal cells in vitro: down-regulation of suppression of the cell cycle inhibitor p57 by HOXA10?. Molecular Human Reproduction. 11(4). 245–251. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026